← Back to All Filings

OHI CEO Awarded Equity Grant; Potential 19.4% Dilution Impact

High SignificanceJanuary 15, 2026 at 11:31:56 PM UTC

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

OHI CEO Awarded Equity Grant; Potential 19.4% Dilution Impact

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: High

Insider: PICKETT C TAYLOR Title: CHIEF EXECUTIVE OFFICER | Relationship: Director, Officer

Transaction: • Type: Grant • Shares: 57,331 • Price: $0.00 • Value: $0 • Owned After: 569,974 units

Key Insight: The CEO received an equity grant representing 19.4% of the company's stated shares outstanding, a highly significant potential dilution event based on provided market data.

Market Context: This is a long-term incentive in the form of Profits Interest Units, which vest in late 2028, intended to align executive interests with long-term shareholder value.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The CEO was awarded equity representing 19.4% of the company's stated shares outstanding, a highly material grant that signals significant potential future dilution.
  • Market Impact: Neutral in the short term, as this is a non-market transaction with a long vesting period, but highlights a major potential increase in share count.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS

Insider Information

FieldValue
NamePICKETT C TAYLOR
CIK0001143567
Title/PositionCHIEF EXECUTIVE OFFICER
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA (Grant)
Security TypeProfits Interest Units
Shares Involved57,331
Price Per Share$0.00
Total Value$0
Shares Owned After569,974
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted57,331
% of Shares Outstanding19.43%
Post-Transaction Ownership569,974 units (193.21% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: While the grant has a transaction value of $0, its size relative to the shares outstanding makes it noteworthy for a company with a $12.99 billion market capitalization.
  • Ownership Concentration: Based on the provided shares outstanding data, the CEO's post-transaction holdings of 569,974 units would represent an impossible 193.21% of the company. This highlights a likely discrepancy in the source market data, but the grant itself still represents a substantial increase in the CEO's potential equity stake.
  • Dilution Impact: The grant of 57,331 shares represents a potential dilution of 19.43% to existing shareholders. This is an exceptionally high level of dilution from a single compensation-related event and is the primary driver of the 'High' significance rating.
  • Transaction Significance: The transaction is deemed 'Highly Significant' not due to its dollar value, but because the number of shares granted exceeds the 0.5% threshold of shares outstanding by a very large margin.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a scheduled executive compensation grant, not an open-market transaction reflecting immediate insider sentiment. The impact is deferred until the shares vest in late 2028.

Volume & Sentiment

  • Expected Volume Impact: None. This is a non-market transaction and does not directly impact trading volume.
  • Sentiment Indicator: Neutral. While the size of the grant is alarming from a dilution perspective, such long-term incentive plans are standard practice to align executive and shareholder interests.

Investment Insights

Positive Market Indicators

  • The grant structure with a three-year vesting cliff aligns the CEO's compensation with the long-term performance of the company.

Risk Factors

  • The primary risk is the extreme potential dilution of 19.43% upon vesting, which could place downward pressure on the stock price if not matched by corresponding growth in company value.
  • The post-transaction ownership percentage calculated from the provided data is illogical, suggesting a potential issue with the shares outstanding figure used for this analysis.

Key Takeaways

  1. OHI's CEO, C. Taylor Pickett, received a grant of 57,331 Profits Interest Units.
  2. The grant represents a potential 19.43% dilution to shareholders, making it a highly significant event based on the provided data.
  3. The units are a form of long-term incentive and will not vest until December 31, 2028, delaying any market impact.

Additional Context

Transaction Notes

  • The securities are Profits Interest Units (PIUs), which are convertible into OP Units. Each OP Unit is redeemable for one share of OHI common stock, making them economically equivalent to a stock grant upon vesting.
Topics:#SECFiling#InsiderTrading#OHI#OmegaHealthcare#Form4#EquityGrant#CEO#StockMarket#Investing#HighSignificance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.